Drug Profile
Research programme: klotho gene therapy - Klogene Therapeutics
Alternative Names: alpha Klotho gene therapy; s-KL gene therapyLatest Information Update: 28 Jul 2023
Price :
$50
*
At a glance
- Originator Universitat Autonoma de Barcelona; Vall d-Hebron Research Institute
- Developer Boston University; Klogene Therapeutics; Universitat Autonoma de Barcelona; Vall d-Hebron Research Institute
- Class Antidementias; Gene therapies
- Mechanism of Action Klotho protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Alzheimer's disease; Amyotrophic lateral sclerosis; Dementia; Multiple sclerosis
Most Recent Events
- 28 Jul 2023 No recent reports of development identified for preclinical development in Amyotrophic-lateral-sclerosis in USA (Parenteral)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Alzheimer's-disease in USA (Parenteral)
- 28 Nov 2021 No recent reports of development identified for preclinical development in Dementia in USA (Parenteral)